News Archives

16 02, 2021

Avance Biosciences™ Expanding Houston Campus
Gallery

Avance Biosciences™ Expanding Houston Campus

webmaster2025-06-13T21:44:41+00:00

HOUSTON, Feb. 16, 2021 /PRNewswire/ -- Avance Biosciences™, a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services supporting biological drug development and manufacturing, announced today that its Houston facility, which successfully passed an inspection by the U.S. Food and Drug Administration in Oct 2018, is undergoing major expansion to handle rapidly growing demand for their services. [...]

Avance Biosciences™ Expanding Houston Campuswebmaster2025-06-13T21:44:41+00:00

5 02, 2021

FDA provides new guidance to industry on manufacture of cell and gene therapy products during COVID-19 pandemic
Gallery

FDA provides new guidance to industry on manufacture of cell and gene therapy products during COVID-19 pandemic

webmaster2025-06-13T21:45:44+00:00

The Center for Biologics Evaluation and Research (CBER) regulates cellular therapy products, human gene therapy products, and certain devices related to cell and gene therapy. CBER uses both the Public Health Service Act and the Federal Food Drug and Cosmetic Act as enabling statutes for oversight. Cellular therapy products include cellular immunotherapies, cancer vaccines, [...]

FDA provides new guidance to industry on manufacture of cell and gene therapy products during COVID-19 pandemicwebmaster2025-06-13T21:45:44+00:00

7 12, 2020

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company
Gallery

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company

webmaster2025-06-13T21:44:42+00:00

Pharm Tech Outlook, a highly respected pharmaceutical/biotech industry magazine, has recognized Avance Biosciences™ as a top 10 Genomics Solutions Company for 2020. Genomic technologies and their usage have seen extensive growth in the past decade. Over the years, these technologies have evolved significantly and can now be used [...]

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Companywebmaster2025-06-13T21:44:42+00:00

12 08, 2020

FDA approves first liquid biopsy next-generation sequencing companion diagnostic test
Gallery

FDA approves first liquid biopsy next-generation sequencing companion diagnostic test

webmaster2025-06-13T21:47:22+00:00

Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC). This is the first approval to [...]

FDA approves first liquid biopsy next-generation sequencing companion diagnostic testwebmaster2025-06-13T21:47:22+00:00

30 10, 2018

Avance Biosciences™ Completes Successful FDA Inspection
Gallery

Avance Biosciences™ Completes Successful FDA Inspection

webmaster2025-06-13T21:44:42+00:00

HOUSTON, Oct. 30, 2018 - Avance Biosciences™, Inc., a leading biological testing company supporting drug development and manufacturing, announced today that its Houston facility was inspected by the U.S. Food and Drug Administration on October 01 through October 04, 2018. This inspection focused on the firm’s quality management system, operation procedures, and data integrity, as [...]

Avance Biosciences™ Completes Successful FDA Inspectionwebmaster2025-06-13T21:44:42+00:00

25 03, 2012

Avance Biosciences™ Signed MSA

webmaster2024-11-12T13:49:51+00:00

In the week of March 18, 2012, Avance Biosciences™ entered a Master Service Agreement (MSA) with a global leader in custom biologics manufacturing. Based on this agreement, Avance Biosciences™ will provide its GMP level Cell Bank Characterization services, including DNA Sequencing, qPCR, Southern blot and other molecular biological methods, to characterize the Master Cell Bank (MCB), Working Cell Bank (WCB), and End of Production Cells (EOPC) submitted by the clients.

Avance Biosciences™ Signed MSAwebmaster2024-11-12T13:49:51+00:00

5 07, 2011

New Website – Avance Biosciences™ Inc.

webmaster2024-11-12T13:50:03+00:00

To Our Esteemed Customers and Friends: We would like to bring to your attention that Avance Biosciences™ Inc. has been formed by a group of experienced genomic scientists, quality professionals, biotechnology services experts, and enthusiastic investors. The founders of the company, combined, have more than 100 years of experience in the genomics and biotechnology [...]

New Website – Avance Biosciences™ Inc.webmaster2024-11-12T13:50:03+00:00

Enhancing Safety and Efficacy – Biodistribution Services for Advanced Cell and Gene Therapies

A historic first for gene therapy

2seventy bio presents broad range of new data highlighting novel approaches across its cell therapies portfolio

Cell Therapy Potency Assay Summit – 2023

New preclinical data from Sana Biotechnology highlights the potential of CAR T cell therapy

NGS for ID and characterization of AAV genomes